Skip to content

   Pharma Publications

Neuropsychopharmacology
  • DRN-SNc serotonergic circuit drives stress-induced motor deficits and Parkinson’s disease vulnerability
    Published on 2025-03-16
    4 months ago
  • Rapid hippocampal synaptic potentiation induced by ketamine metabolite (2R,6R)-hydroxynorketamine persistently primes synaptic plasticity
    Published on 2025-03-16
    4 months ago
  • Lateral habenula induces cognitive and affective dysfunctions in mice with neuropathic pain via an indirect pathway to the ventral tegmental area
    Published on 2025-03-14
    4 months ago
  • Brain reactivity to nicotine cues mediates the link between resting-state connectivity and cue-induced craving in individuals who smoke or vape nicotine
    Published on 2025-03-12
    4 months ago
  • Metabolomic profiling of cannabis use and cannabis intoxication in humans
    Published on 2025-03-11
    4 months ago
  • Brain structural correlates of an impending initial major depressive episode
    Published on 2025-03-11
    4 months ago
  • Paternal heroin self-administration in rats increases drug-seeking behavior in male offspring via miR-19b downregulation in the nucleus accumbens
    Published on 2025-03-07
    4 months ago
« Previous 1 … 10 11 12 13 14 … 143 Next »
Journal of Psychopharmacology
  • Hemispheric annealing and lateralization under psychedelics (HEALS): A novel hypothesis of psychedelic action in the brain
    Published on 2024-12-20
    7 months ago
  • Navigating agitation in neurodevelopmental disorders: A comparative study of pharmacotherapies via network meta-analysis in children and adults with autism spectrum disorder or intellectual disabilities
    Published on 2024-12-18
    7 months ago
  • Is there a risk of addiction to ketamine during the treatment of depression? A systematic review of available literature
    Published on 2024-12-17
    7 months ago
  • Metformin efficacy and safety as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double-blind, placebo-controlled trial
    Published on 2024-12-16
    7 months ago
  • Antipsychotic polypharmacy and high-dose antipsychotic therapy compared to antipsychotic monotherapy at standard doses in schizophrenia – a systematic review
    Published on 2024-12-10
    7 months ago
  • Psychedelics as an intervention for psychological, existential distress in terminally ill patients: A systematic review and network meta-analysis
    Published on 2024-12-10
    7 months ago
  • Habitual caffeine intake, genetics and cognitive performance
    Published on 2024-12-09
    7 months ago
« Previous 1 … 10 11 12 13 14 … 123 Next »
European Neuropsychopharmacology
  • Predicting the past: The risks and rewards of post-hoc findings
    Published on 2024-12-22
    7 months ago
  • Retinal structure and its relationship with premorbid, clinical, and cognitive variables in young Spanish patients with early course schizophrenia spectrum disorders
    Published on 2024-12-22
    7 months ago
  • Redefining schizophrenia treatment with muscarinic modulation—A perspective
    Published on 2024-12-06
    7 months ago
  • Examining the impact of comorbid posttraumatic stress disorder on ketamine’s real-world effectiveness in treatment-resistant depression
    Published on 2024-12-06
    7 months ago
  • Dilemmas in psychedelic medicine: From ethics to regulation and equity
    Published on 2024-12-05
    7 months ago
  • Sex-stratified mortality estimates in people with schizophrenia: A systematic review and meta-analysis of cohort studies of 2,700,825 people with schizophrenia
    Published on 2024-12-03
    7 months ago
  • Risk of mortality and complications in people with depressive disorder and diabetes mellitus: A 20-year population-based propensity score-matched cohort study
    Published on 2024-11-30
    7 months ago
« Previous 1 … 10 11 12 13 14 … 144 Next »

   Pharma Pub